The major outer membrane protein OprF of Pseudomonas aeruginosa plays a dual role, acting both as a porin, forming water-filled channels through the outer membrane (26, 40) , and as a structural protein important for the maintenance of cell shape and growth on low-osmolarity media (39) . There has been some controversy, based on in vitro model membrane data, regarding the size exclusion limit of pores formed by OprF (27, 31, 41) . However, recent in vivo data from our laboratory, utilizing P. aeruginosa strains containing a cloned raffinose utilization operon in growth and plasmolysis studies, have indicated that OprF represents the major porin permitting uptake of di-to tetrasaccharides (1) . The structural role of OprF is analogous to that of OmpA, a major outer membrane protein of Escherichia coli (32, 39) . OprF and OmpA are immunologically cross-reactive, the two proteins demonstrate 33% identity and 55% similarity of amino acid sequences in their carboxy-terminal halves, and cloned OprF appeared to be able to substitute for the structural role of OmpA in an lpp mutant background (39) . Recently, Nikaido et al. (27, 33) demonstrated that OmpA can reconstitute a porin function in liposomes.
Models of the arrangement of OmpA within the outer membrane have placed the amino-terminal half in the membrane and the carboxy-terminal half of the protein in the periplasm (2, 9, 21, 36) . Although there is reasonable data favoring the disposition of the amino-terminal half of OmpA as 3-strands crossing the membrane with intervening loop regions (21) , evidence that the entire carboxy-terminal half * Corresponding author.
of OmpA is periplasmic is largely indirect. This evidence includes cleavage of OmpA by pronase to a proteaseresistant core structure comprising the amino-terminal 177 amino acids (4) , demonstration by molecular genetic manipulations that less than the amino-terminal 193 residues must be present to result in an outer membrane-associated product (2) , and exclusive localization of amino acids involved in binding of OmpA-specific phage to the amino-terminal half (21) . Interestingly, as demonstrated in part both previously (24) and in this study, OprF shares the first two of these properties.
We previously published (31) a model for OprF in which the entire protein was presented as transmembrane 1-strands connected by loops of amino acids. This model was based on estimates of the total amount of 1-sheet structure by using circular dichroism (19, 31) and the protein structure prediction methods of Paul and Rosenbusch (28) . However, while the model presented for OprF was compatible with models for other porin proteins (3, 35, 36) , the proposed membrane disposition of the carboxy-terminal half differed markedly from the proposed periplasmic localization of the equivalent region from OmpA (2, 9, 21) . In this study, we have utilized a series of monoclonal antibodies, as well as the products of molecular genetic manipulations of the cloned oprF gene, in part to assess which of these proposed arrangements of the carboxy terminus applied to OprF.
Many investigators have applied the TnphoA mutagenesis system developed by Manoil and Beckwith (17) to study the topology and export of cytoplasmic membrane proteins (16, 37) , although it has shown limited value for studying topol-ogy of outer membrane proteins (5, 11, 22, 23 (20) ] were utilized as the host strains for most plasmids. Plasmids pWW2200, expressing the intact oprF gene (38) , and pWW5, expressing a truncated product (40), were described previously. Plasmid pWW12 was created during subcloning of oprF into the plasmid pLAFrl (38) . It contained an 11.2-kbp EcoRI fragment encoding a truncated P. aeruginosa OprF. Plasmids pWW1901 and pWW1602 were produced by subcloning 3.0-and 1.2-kbp Sall fragments from plasmid pWW13 (40) into plasmid vector pUC8 (20) . These fragments represented the amino and carboxy terminus-encoding parts of the oprF gene, respectively. The culture medium used for all E. coli strains in this study was Luria broth (LB) (1% tryptone, 0.5% yeast extract, 1% NaCl). Solid LB medium contained 2% agar. All medium components were from Difco Laboratories, Detroit, Mich. Strains were grown at 37°C with agitation overnight. Cells destined to be made competent were grown at 37°C with agitation to an optical density at 600 nm of 0.2 to 0.4.
Antibiotic concentrations used were 12.5 p,g of tetracycline (Tc) per ml and 50 ,ug of kanamycin (Km) per ml. To test for clones producing alkaline phosphatase, 5-bromo-4-chloro-3-indolyl phosphate (X-P; p-toluidine salt; BaChem, Philadelphia, Pa.) was dissolved in dimethyl sulfoxide and used at a concentration of 20 mg/ml in LB agar. Strains were stored for short terms on plates at 4°C and for long terms in 8% dimethyl sulfoxide at -70°C. Bacteriophage XTnphoA (b221 cI857 Pam3 with TnphoA in or near rex [12] ) was propagated in a 0.6% LB agar overlay on the permissive host E. coli LE392[F-hsdr514(rK-MK-) supE44 supF58 lacYl or A(lacIZY)6 galK2 galT22 metBI trpR55 X- (29) ].
TnphoA mutagenesis. TnphoA mutagenesis of the OprFencoding plasmid pWW2200 (38) was carried out as follows. E. coli TB1/pWW2200 grown in LB supplemented with 10 mM MgSO4 to an optical density at 600 nm of 0.5 were infected with XTnphoA at a multiplicity of infection of 1. Successful transpositions were selected on LB plates containing tetracycline to select for maintenance of the plasmid and kanamycin to select for the presence of the transposon. To separate successful transpositions onto plasmid DNA from chromosomal transposon mutants, plasmid DNA was isolated from the pool of doubly resistant colonies and the pooled plasmid preparation was used to transform strain CC118. Transformants were again selected for tetracycline and kanamycin resistance on LB plates and screened for production of alkaline phosphatase (PhoA) by inclusion of X-P in the medium. A total of 96 blue colonies and 500 white colonies from 10 separate transfections of E. coli TB1/ pWW2200 were collected from LB agar plates containing kanamycin, tetracycline, and the alkaline phosphatase indi- (Table 1) . Monoclonal antibodies and polyclonal sera. The OprFspecific monoclonal antibodies MA4-4 and MA5-8 were described previously (24) . Monoclonal antibody 7-3, proposed for use in identifying P. aeruginosa in in vivo samples, was previously designated IG1 (6) . Monoclonal antibodies MA7-1, MA7-2, and MA7-4 through MA7-8 were isolated by a similar protocol at Oncogen Co., Seattle, Wash. (6). Antiserum to E. coli bacterial alkaline phosphatase, a-BAP, was purchased from 5 Prime --3 Prime (Boulder, Colo.).
DNA techniques. For large-scale isolation of plasmid DNA, alkaline lysis and then centrifugation in ethidium bromide-cesium chloride density gradients were used (32) . For rapid small-scale isolation of plasmid DNA, the same alkaline lysis method was used without subsequent density gradient centrifugation. Plasmid DNA was quantitated by a fluorescence spectrophotometric assay (15) with the DNAbinding fluorochrome H33258 (Hoefer, San Francisco, Calif.).
Restriction enzyme digests, agarose gel electrophoresis, and transformations were carried out as described by Sambrook et al. (29) . The restriction endonuclease patterns of all plasmids were checked regularly to ensure that the patterns were stable and that no recombination events occurred. E. coli strains were made competent by using 0.1 M CaCl2 (29 (34) , whereas that of pWW5 used a similar approach except that the automated sequencer was employed as described above.
Cell fractionation and SDS-PAGE. Total cellular protein was solubilized as described previously (25) . Outer membranes were isolated by the method of Schnaitman (30 (24) . Western immunoblotting after separation by SDS-PAGE was performed as described previously (39, 40) . Immunodetection, with a horseradish peroxidase-conjugated second antibody, was by the method of Harlow and Lane (14 (Fig. 3) . e See Fig. 1 bodies MA7-2 ( Fig. 1, lanes B and C) and MA7-6, corresponded better to the predicted molecular mass of the OprF portion of the fusion protein (Table 2 ). These fusion proteins, which apparently contained all but the last 27 or 37 amino acids of OprF, appeared to be unstable and subject to degradation. The degradation products observed in the case of both fusions ran at the same molecular weight as an OprF degradation product frequently seen when this protein is expressed in E. coli (Fig. 1, cf . lanes E and F). Attempts to overcome degradation by expressing the fusion proteins in E. coli backgrounds deficient in protease activity (8, 10) were unsuccessful. The main immunodetectable product in both backgrounds was still the degradation product.
In the case of the fusion at amino acid 180 in plasmid pRF13, two immunodetectable products corresponding to the predicted molecular mass (Fig. 2, M) and to more than twice the predicted molecular mass (Fig. 2, 10 min, run on SDS-11% PAGE, and transferred to nitrocellulose. The heat-modified (F*) and non-heat-modified (F) forms of OprF are indicated on the left, and molecular size markers in kilodaltons are indicated on the right. Lanes A and F, CC118(pWW2200); lanes B and D, CC118(pRF16); lanes C and E, CC118(pRF15). Lanes A to C were reacted with MA7-2; lanes D to F were reacted with MA4-4. The faint bands observed in lanes B to E at the running positions of 34 and 40 kDa were present in the CC118 negative controls and represent OmpA and an unknown outer membrane protein, respectively. In addition, the minor reactivities of monoclonal antibodies with oligomeric forms and protease degradation products of OprF, as previously described (24) , occurred in the positive control (lanes A and F).
FIG. 2. Immunoreactivity with MA7-1 of OprF fusions to PhoA
at amino acids 144 (in pRF11) and 180 (in pRF13). Outer membrane preparations were heated at 100°C for 10 min, run on SDS-11% PAGE, and transferred to nitrocellulose. The heat-modified, mercaptoethanol-modified (F'*); heat-unmodified, mercaptoethanolmodified (F'); and heat-unmodified, non-mercaptoethanol-modified (F) forms of OprF and the monomeric (M) and proposed oligomeric (D) form of the fusion at amino acid 180 are indicated. Molecular size markers in kilodaltons are indicated on the right. Lanes A and E, CC118(pRF13); lane B, CC118(pRF11); lane C and D, CC118(pWW2200). Lanes A to C, untreated; lanes D and E, treated with 2-mercaptoethanol (nota bene: OprF changes mobility upon reduction of its disulfides with 2-mercaptoethanol, running at a higher apparent molecular weight and with a greater tendency to heat modify [13] (Table 2) , failed to react with any of the 10 monoclonal antibodies tested. Outer membranes were prepared from strains producing fusion proteins detectable by anti-OprF monoclonal antibodies (i.e., those from plasmids pRF13 to pRF16). The fusion proteins were detectable in the outer membrane fractions of the cells but not in the cytoplasmic and periplasmic fractions. To confirm this, we examined, by indirect immunofluorescence, the reactivities of three specific monoclonal antibodies with cells producing no OprF, intact OprF, or one of the OprF fusion peptides. The data confirmed surface localization of the epitopes of monoclonal antibodies against the N terminus (MA7-1), middle (MA4-4), and C terminus in the E. coli clones (Table 3 ). In addition, the pattern of reactivity was in direct agreement with the results from colony and Western immunoblots. This indicated that these products were transported to the E. coli outer membrane. The carboxy-terminal half of OprF, therefore, appeared to be nonessential for export to the outer membrane.
Epitope localization with OprF::TnphoA derivatives. The MA4-4 epitope (24) and MA7-8 epitope (Fig. 3) were both lost upon treatment of OprF with 2-mercaptoethanol (see also Table 4 ). This implicated one or both of the predicted (31) disulfide bonds as being essential for the formation of these epitopes. The fusion at Asp-180 (in plasmid pRF13) which eliminated three of the four cysteines, and hence the ability to form disulfides, was not reactive with MA4-4 or MA7-8. In contrast, the fusion at Gly-204 (in plasmid pRF14), which retained the first pair of cysteine residues but lacked the second pair, was still reactive with these monoclonal antibodies (Fig. 3) . Consequently, the MA4-4 and MA7-8 epitopes could be localized in part to between Cys-176 and Gly-204. MA4-4 and MA7-8 were raised against OprF in separate procedures in separate laboratories, but there is nevertheless a distinct possibility that they recognize the same epitope. Reactivity, with MA4-4 of the pRF14-encoded fusion (Fig. 3 , lane E), like that with intact OprF ( Fig. 3, lane F) , was destroyed by 2-mercaptoethanol treatment.
The epitopes for MA7-2 and MA7-6 could be localized in part to the region between Gly-204 and Gly-289 on the basis of the observation that OprF fusions at Gly-204 (in plasmid pRF14) were nonreactive, while OprF fusions at Gly-289 (in plasmid pRF15) and Ser-299 (in plasmid pRF16) both retained reactivity with these monoclonal antibodies ( Table 2 ). The immunoreactive product in the case of both of these fusions was not the predominant degradation product but the more weakly detectable band corresponding to the predicted molecular weights of the OprF portions (Fig. 1 , lanes B and C; Table 2 ). The degradation products were not detectable by either MA7-2 or MA7-6. The MA7-2 and MA7-6 epitopes appeared to be distinct, since reactivity of intact OprF with MA7-2 was unaffected by 2-mercaptoethanol treatment whereas reactivity with MA7-6 was weakened by 2-mercaptoethanol treatment (Table 4) .
None of the OprF fusion proteins generated in this study were reactive with MA5-8, MA7-3, MA7-4, MA7-5, and MA7-7 ( Table 2) .
Reactivity of anti-OprF monoclonal antibodies with other OprF derivatives. Data regarding the locations of the epitopes recognized by the anti-OprF monoclonal antibodies, based on analyses of the truncated OprF derivatives created by TnphoA mutagenesis, were complemented by the monoclonal antibody reactivity patterns of OprF derivatives created by subcloning. The amino-terminal (start to the SalI site) and carboxy-terminal (Sall to end) coding regions of oprF were subcloned to give pWW1901 and pWW1602, respectively (Fig. 4) . The other two OprF derivatives, pWW5 (40) and pWW12, arose during the original subcloning of the oprF gene. Sequencing of pWW5 and pWW12 in the present study revealed that pWW5 encoded an OprF with an internal deletion from amino acid 171 through 300, whereas pWW12 encoded an OprF derivative which was truncated at amino acid 273. The sequence data for these subclones are summarized in Fig. 4 , and the immunoreactivities of the proteins produced by these subclones are presented in Table 4 and Fig. 5 . Consistent with the above data, monoclonal antibodies MA7-1, MA4-4, and MA7-8 reacted with the N-terminal first 187 amino acids, the product of pWW1901. The other seven monoclonals all interacted with the carboxy-terminal product of pWW1602 expressing amino acids 188 to 326. The apparent molecular weight of this immunoreactive product on Western immunoblots of 2-mercaptoethanol-reduced protein was 16,000 (18) . The product of pWW12, expressing amino acids 1 to 273, behaved similarly to the products of pRF15 and pRF16, expressing amino acids 1 to 289 and 1 to 299, respectively, in that pWW12 produced a protein, with the predicted molecular weight of the OprF-encoding portion, which was reactive with MA7-2 and MA7-6. This protein tended to break down to a product of the same apparent molecular weight as a normal proteolysis product of OprF (Fig. 5 , lanes E and F). Both of these products lost reactivity to MA7-2 and MA7-6 but retained reactivity with MA7-1, MA4-4, and MA7-8 (Tables 2 and 4 ). Plasmid pWW5 arose as a result of an internal deletion due to an apparent recombination between the identical DNA sequences, CCGGTTGCCGAC, that begin at nucleotide positions 583 and 973 of the oprF coding sequence (1,053 bp total). The resultant deletion protein had lost the region encoding the four cysteines of OprF and most of the carboxy-terminal region of OprF except amino acids 301 to 326. The resultant protein, which had a predicted molecular weight of 22,000 and an apparent molecular weight of 24,000 (40) (Fig. 5) , retained reactivity only with MA7-1 and MA5-8.
DISCUSSION
In this manuscript, we have utilized a series of truncated OprF derivatives, created by TnphoA mutagenesis, in addition to others created by subcloning, to map the epitopes of a series of monoclonal antibodies within the OprF gene. We have previously presented data suggesting that OprF, when expressed in E. coli, is exported to the outer membrane and capable of reconstituting channels with characteristics the same as those of OprF from P. aeruginosa (40) . Furthermore, on the bases of 2-mercaptoethanol reduction experiments and the ability of OprF to react with two OprFspecific monoclonal antibodies (Table 4) , it would seem that the intrachain cysteine disulfide(s) formed by this protein in P. aeruginosa is also formed in E. coli. As judged by colony immunoblotting (for antibodies MA4-4 and MA7-8) and indirect immunofluorescence studies (for MA4-4), the epitopes for both antibodies are recognized in E. coli cells.
These results strongly suggest that OprF is exported to the outer membrane of E. coli and folds in a manner similar to that of native OprF in P. aeruginosa. Consistent with this we have shown that a further eight OprF-specific monoclonal antibodies react with E. coli-derived OprF (Table 4) , which is consistent with the above results. Although we cannot conclude that the immunoreactive, truncated OprF derivatives studied here were also folded correctly, the observations that they were apparently exported to the outer membrane (Table 3) , were capable of reacting on colony and Western immunoblots with between 1 and 7 of the 10 OprF-specific monoclonal antibodies, and for those truncated OprF derivatives with more than one pair of cysteines, produced at least one cysteine disulfide (Fig. 3) suggested that these derivatives might have retained some of the folding patterns of native OprF. Nevertheless, it must be stressed that the conclusions made below regarding the localization of epitopes are based on Western immunoblot studies after transfer of the truncated OprF derivatives from SDS-PAGE to nitrocellulose. Therefore, the conclusions regarding epitope localization are based on the immunoreactivity of partially denatured truncated OprF derivatives and not on a presumption of retention of secondary or tertiary structure in these derivatives.
The locations of the various epitopes for the 10 monoclonal antibodies studied are described in Fig. 4 . The MA7-1 epitope was delineated by the reactivity of MA7-1 with all products containing the amino-terminal 170 amino acids, including pRF13-16 (Table 2) , pWW1901, pWW12, and pWW5 (Table 4 ). The lack of reactivity of the protein produced by pRF12 with MA7-1 (Table 4) was consistent with a conclusion that part of the epitope for MA7-1 lies between amino acids 153 (the fusion joint in pRF12) and 170 (in pWW5). However, we could not conclude that the entire epitope lies in this region, and an 8-kDa variance in the predicted and apparent molecular masses of the oprF::
TnphoA fusion protein from pRF12 weakened this conclusion. The epitopes for MA7-2 and MA7-6 were localized to amino acids 188 to 326 by reactivity with the product of plasmid pWW1602 (Table 4 ). The carboxy-terminal extension of these epitopes was further delineated by reactive clones pWW12 (amino acids 1 to 273), pRF15 (1 to 289), and pRF16 (1 to 299) and nonreactive clone pWW5, whereas clones that failed to react with MA7-2 and MA7-6 included pRF14 (1 to 204) and the major (degradation) products of the above reactive clones (estimated to be slightly larger than the pRF14 product on the basis of gel mobility). Therefore, amino acids 204 to 273 appear to contain at least part of these epitopes, whereas the involvement of amino acids 188 to 204 is uncertain. These two monoclonal antibodies have epitopes that are different as determined on the basis of the observations that MA7-6 recognizes a surface epitope whereas MA7-2 apparently does not, and the two monoclonal antibodies have different patterns of reactivity against other fluorescent Pseudomonas species (19) . Monoclonal antibody MA5-8 recognized an epitope between amino acids 301 and 326 on the basis of its reactivity with the product of pWW1602 (encoding amino acids 188 to 326) and pWW5 (encoding only amino acids 301 to 326 of the pWW1602-encoded region of OprF) but lack of reactivity with the oprF::TnphoA fusion products (Table 2 ) and with the product of pWW12 (Table 4) . Monoclonal antibody MA5-8 recognizes a surface epitope as determined on the basis of immunofluorescence of intact cells and phagocytosis opsonization data (24) .
The epitopes for monoclonal antibodies MA7-3, MA7-4, MA7-5, and MA7-7 were localized to the carboxy terminus (amino acids 188 to 326) on the basis of reactivity with the product of pWW1602. However, these monoclonal antibodies failed to react with any of the products of the oprF: :TnphoA fusions or with the products of the pWW12 or pWW5 subclones. The amino-terminal extension (amino acid 204) of the epitope for these monoclonal antibodies was implied from the lack of reactivity of the protein produced by cells containing pRF14 and of the major truncated products produced by cells containing pRF15, pRF16, or pWW12 (we did not consider the lack of reactivity of the minor bands produced from these clones as definitive given their poor production [ Fig. 1]) . The carboxy-terminal extension of the epitopes was indicated to lie at amino acid 300 on the basis of lack of reactivity with the protein expressed by pWW5.
On the basis of mobility shifts in the presence of 2-mercaptoethanol, Hancock and Carey (15) proposed that OprF contained two disulfide bonds. In a recent model of OprF (31) , we placed these bonds for convenience between neighboring disulfide residues. The resultant loop regions between the bonds were arranged at the cell surface on the basis of the observation that reactivity with MA4-4, a monoclonal antibody that recognizes surface epitopes (24) , was lost upon treatment of OprF with 2-mercaptoethanol (Fig. 3) . The data presented here favor the hypothesis that the secondary structure created by a disulfide bond between Cys-176 and another cysteine residue possibly forms the epitope recognized by MA4-4 and MA7-8. The other cysteine residue involved is probably not Cys-205 or Cys-192, as evidenced by the fact that a clone expressing amino acids 1 to 187 of OprF [in TBl(pWW1901)], which would lack both these cysteines, is still reactive with MA4-4 and MA7-8. Also, the fusion at amino acid 204 in pRF14 (which would lack Cys-205) retained reactivity with both MA4-4 and MA7-8 (Fig. 2) . In addition, fusion pRF13 containing amino acids 1 to 180 and subclone pWW5 containing amino acids 1 to 170 VOL. 174, 1992 on June 19, 2017 by guest http://jb.asm.org/ Downloaded from failed to react with these two monoclonal antibodies, indicating that both Cys-176 and Cys-185 may be required for this epitope. The OprF proteins of both P. aeruginosa and P. syringae are identical in sequence between these cysteines but diverge substantially at their amino termini (34) . Since both react with MA4-4 (24, 34) and MA7-8 ( Fig. 2) (28) , is consistent with the measured content of P-sheet structure in OprF (19) . The results of the present study are consistent with our previous model since several monoclonal antibodies recognizing surface epitopes (19, 24) , including MA5-8, MA7-3, MA7-4, MA7-5, MA7-6, and MA7-7, map to the region of OprF related to the carboxy terminus of OmpA, whereas MA4-4 and MA7-8 map to the cysteine region that has been apparently inserted into this region of homology.
